Arterial stiffness moderates the link between NfL and cognition: The IGNITE study

Alzheimers Dement. 2025 Aug;21(8):e70554. doi: 10.1002/alz.70554.

Abstract

Introduction: Arterial stiffness (carotid-femoral pulse wave velocity [cfPWV]) and plasma neurofilament light (NfL), markers of vascular and neuroaxonal aging, are linked to cognitive decline. Whether higher cfPWV amplifies the NfL-cognition relationship remains unclear.

Methods: Cognitively unimpaired older adults (N = 570) were assessed using composite cognitive scores from confirmatory factor analysis. cfPWV was dichotomized at the median. Plasma NfL was quantified on a Single Moleculte Array-High Definition, model X (SIMOA-HD X).

Results: Higher NfL correlated with poorer performance across all cognitive domains (p < 0.05), and higher cfPWV was linked to worse episodic memory, working memory, and processing speed (p < 0.05). NfL× cfPWV interactions were significant for episodic (β = 0.289, p = 0.048) and working memory (β = 0.287, p = 0.025), with stronger NfL-cognition associations in the higher cfPWV group (episodic memory: β = -0.324, p < 0.01; working memory: β = -0.343, p < 0.01).

Discussion: Greater cfPWV amplified the association between NfL-related axonal degeneration and cognitive decline.

Trial registration: ClinicalTrials.gov: NCT02875301 HIGHLIGHTS: Neurofilament light (NfL) and carotid-femoral pulse wave velocity (cfPWV) each correlate with poorer cognitive function in older adults. Higher cfPWV exacerbates the link between NfL and cognitive deficits. Arterial stiffness may worsen NfL-related cognitive decline. Findings reveal synergy between vascular and neurodegenerative aging markers. Examining NfL or cfPWV alone may miss their synergistic effects on cognition.

Keywords: cardiorespiratory fitness; cognitive aging; episodic memory; neurofilament light; older adults; pulse wave velocity; vascular health; working memory.

Publication types

  • Clinical Trial, Phase III
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Carotid-Femoral Pulse Wave Velocity
  • Cognition* / physiology
  • Cognitive Dysfunction* / blood
  • Cognitive Dysfunction* / physiopathology
  • Female
  • Humans
  • Male
  • Neurofilament Proteins* / blood
  • Neuropsychological Tests
  • Pulse Wave Analysis
  • Vascular Stiffness* / physiology

Substances

  • Biomarkers
  • neurofilament protein L
  • Neurofilament Proteins

Associated data

  • ClinicalTrials.gov/NCT02875301